(Q34565164)

3 August 2017

title

Sulindac causes regression of rectal polyps in familial adenomatous polyposis (English)

1 reference

3 August 2017

1 reference

D. Labayle

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1650315

21 October 2022

D. Fischer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1650315

21 October 2022

P. Vielh

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1650315

21 October 2022

F. Drouhin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1650315

21 October 2022

A. Pariente

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1650315

21 October 2022

C. Bories

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1650315

21 October 2022

O. Duhamel

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1650315

21 October 2022

M. Trousset

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1650315

21 October 2022

P. Attali

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1650315

21 October 2022

publication date

1 September 1991

1 reference

full work available at URL

3 August 2017

language of work or name

English

0 references

https://api.elsevier.com/content/article/PII:001650859190519Q?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90519-Q

https://api.elsevier.com/content/article/PII:001650859190519Q?httpAccept=text/plain

21 October 2022

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90519-Q

21 October 2022

1 reference

3 August 2017

volume

101

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

635-639

1 reference

Surgical management of multiple polyposis. The problem of cancer in the retained bowel segment

3 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90519-Q

Sulindac for polyposis of the colon

21 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90519-Q

Sulindac treatment for familial polyposis coli

21 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90519-Q

Sulindac for polyposis of the colon.

21 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90519-Q

Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

21 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90519-Q

Postcolectomy regression of adenomatous polyps of the rectum

21 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90519-Q

Regression of rectal adenomas after colectomy and ileorectal anastomosis for familial adenomatous polyposis

21 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90519-Q

Evidence that indomethacin reversibly inhibits cell growth in the G1 phase of the cell cycle

21 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90519-Q

Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment

21 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90519-Q

Skin cancers in xeroderma pigmentosum: response to indomethacin and steroids

21 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90519-Q

Regression of Head and Neck Carcinoma With a Prostaglandin-Synthesis Inhibitor

21 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90519-Q

The disposition of sulindac

21 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90519-Q

Identification of the biologically active form of sulindac

21 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90519-Q

Immunohistochemical study of epithelial cell proliferation in hyperplastic polyps, adenomas, and adenocarcinomas of the large bowel

21 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90519-Q

21 October 2022

Identifiers

0 references

1 reference